Thank you @alexandrosM for recognizing providers who are still committed to their oath, courageous enough to make decisions, and bold enough to apply the latest data to treat patients. "And that's why, even though they're not always right, they're always less wrong than most." https://t.co/Ra0AaUqRJn
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 18, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 18, 2022
Twitter
Alexandros Marinos
Heparin. Where have I heard this before? Ah. The "H" in the MATH+ protocol. It still blows my mind how much the good folks at FLCCC have gotten correct, and how much earlier than most, and how much shit they've gotten for their trouble. twitter.com/Undergroundcou…
Yvette Purdie's husband was critically ill with COVID and bedridden for 10 days. Watch as she tells her story of his miraculous recovery and how he was finally able to get out of bed. https://t.co/qPG1ssl7ix https://t.co/ZFgdxZ0q0C
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 19, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 19, 2022
Odysee
MyStory: Yvette Purdie
Watch as Yvette tells her story about her and her husband contracting COVID-19. Her husband was bedridden, clinging to life, until on day 10 he received his first dose of ivermectin. Miraculously, his...
Has COVID eroded the doctor/patient relationship? One East Texas ER doctor thinks it may have. https://t.co/ma5hZlM4lc "Quite frankly, as physicians, we need to function better in this environment.” https://t.co/T7IFEiYAqy
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 19, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 19, 2022
www.texmed.org
Emergency Doc Finds Building Patient Trust More Difficult During COVID
As the COVID-19 pandemic languishes into its third year, physicians continue to bear the brunt of its impact, from unpredictable surges to worsening burnout. Craig Meek, MD, an emergency medicine physician in East Texas and president of the Texas College…
FLCCC DOCTORS: JAMA Ignores Peer-Reviewed Evidence & Publishes Yet Another Misleading, Underpowered IVM Study. https://t.co/3t0Ide2QY7
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 19, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 19, 2022
The FLCCC Alliance Community
JAMA Ignores Peer-Reviewed Evidence & Publishes Yet Another Misleading, Underpowered IVM Study
FLCCC Doctors: “We treat patients, not p-values."
Forwarded from BiRD Group Channel (Tessarary)
There have been some assumptions in the media that the new JAMA article is somehow definitive on the matter of ivermectin for covid-19 treatment.
The BiRD team encourages you to see this trial conducted in Malaysia in context of the large body of evidence on ivermectin, including randomised trials, country studies and doctor/patient experiences (qualitative data).
The JAMA trial is far from gold-standard, in that it is open label, underpowered and without a funding statement. It was also conducted among high risk patients with other health problems only so may be relevant to only a subset of people.
The study was not powered to detect a difference in death rates, however fewer deaths occurred among patients receiving ivermectin compared with controls (3 versus 10 people died, respectively). This may be an important finding, which is corroborated by other scientists and frontline doctors.
The following would therefore be a more appropriate conclusion: "The study findings suggest that ivermectin given on its own to high risk covid-19 patients with co-morbidities may make little or no difference to the course of their disease; however, our study was underpowered to detect a statistically significant difference in deaths. 🕊🕊🕊https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362
The BiRD team encourages you to see this trial conducted in Malaysia in context of the large body of evidence on ivermectin, including randomised trials, country studies and doctor/patient experiences (qualitative data).
The JAMA trial is far from gold-standard, in that it is open label, underpowered and without a funding statement. It was also conducted among high risk patients with other health problems only so may be relevant to only a subset of people.
The study was not powered to detect a difference in death rates, however fewer deaths occurred among patients receiving ivermectin compared with controls (3 versus 10 people died, respectively). This may be an important finding, which is corroborated by other scientists and frontline doctors.
The following would therefore be a more appropriate conclusion: "The study findings suggest that ivermectin given on its own to high risk covid-19 patients with co-morbidities may make little or no difference to the course of their disease; however, our study was underpowered to detect a statistically significant difference in deaths. 🕊🕊🕊https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362
#LetDoctorsBeDoctors https://t.co/deREKKUEVR
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 20, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 20, 2022
Twitter
FLCCC—Front Line COVID-19 Critical Care Alliance
#LetDoctorsBeDoctors
Make sure you have the right ingredients on hand for your just-in-case COVID kit. Here's what to look for: https://t.co/Ydz0s3xMbG https://t.co/e97E7PiDq4
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 20, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 20, 2022
Odysee
Your shopping list for the FLCCC's recommended Just in Case Covid Kit
In this FLCCC How to video, we discuss what you need to shop for to put together your Just in Case Covid Kit. The FLCCC does not sell these ready made kits therefore you have to go out and purchase th...
American truckers are launching The People’s Convoy February 23 from Adelanto Stadium in Southern California and @PierreKory will be there to encourage and send them off. https://t.co/NzTEOYSfwY https://t.co/smC8kRdste
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 21, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 21, 2022
Twitter
PeoplesConvoyUSA (@peoplesconvoyus) | Twitter
The latest Tweets from PeoplesConvoyUSA (@peoplesconvoyus). Rolling out from Adelanto, CA on 2/23/22
“The truth & the facts do not matter because the outcome is predetermined and the process is rigged.” Have sham peer reviews become commonplace in medicine? According to Dr. Marik, they have. Join us for our webinar tomorrow at 7 pm for more discussion: https://t.co/FrUfC7Hkj8
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 22, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 22, 2022
The FLCCC Alliance Community
‘Sham Peer Review’: How hospitals exert control over physicians who dare to speak out
Hospitals can use these proceedings to oust doctors who don’t follow the ‘party line’, or who are considered disruptive.
Forwarded from Dr Naomi Wolf
South Carolina Attorney General Alan Wilson rules doctors can prescribe Ivermectin, Hydroxychloroquine
https://www.wnd.com/2022/02/state-ag-rules-doctors-can-prescribe-ivermectin-hydroxychloroquine/
Subscribe ➡️⬇️➡️ @naomirwolf
https://www.wnd.com/2022/02/state-ag-rules-doctors-can-prescribe-ivermectin-hydroxychloroquine/
Subscribe ➡️⬇️➡️ @naomirwolf
WND
State AG rules doctors can prescribe ivermectin, hydroxychloroquine
Asked to provide a legal opinion on hospitals in the state banning doctors from prescribing certain treatments for COVID-19, South Carolina Attorney General Alan Wilson concluded doctors have the authority to prescribe drugs for the disease "off-label," such…
Truckers are arriving, volunteers are organizing donations, and plans are being finalized for tomorrow’s launch of the People’s Convoy. Find out more: https://t.co/wF7IkBEYd1 https://t.co/OA1b71Vh0S
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 22, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 22, 2022
Speakers will begin to take the stage soon with words of inspiration for the truckers and their supporters. The energy is building, horns are honking, Canadian flags waving in support. Freedom is in the air! https://t.co/a4luk575Px https://t.co/pl05wOTYEd
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 23, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 23, 2022
“We’re here for principles. When we doctors start to talk about what works and what doesn’t work, we get censored. We’re here trying to save lives just like all of you are here to save lives.” Dr Pierre Kory speaks at the launch of the #peoplesconvoy https://t.co/BLVPtJ2W3q https://t.co/fnFZOgw5Pj
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 23, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 23, 2022
YouTube
Trucker Convoy Ready to Start Cross-Country Trip
Supporters of the People's Convoy prepare to launch their cross-country trip to protest federal COVID policies.
Thank you for sharing @SeivwrightTrudy! https://t.co/BLgevBKkYu
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 24, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 24, 2022
Twitter
Trudy Seivwright MD
🧵🧵Amazon Smile will donate 0.5% of the price of your eligible Amazon purchases to FLCCC! Simply type: “Front Line Covid 19 Critical Care Alliance Inc” in the Amazon Smile non-profit organization search bar, hit select, and you’re ready to go.
Forwarded from KanekoaTheGreat
Media is too big
VIEW IN TELEGRAM
WATCH - Dr. Peter McCullough on JAMA's recent underpowered Ivermectin study. The study showed a reduction in mortality in the ivermectin group, but the headline was written as if ivermectin failed.
"There's a signal of benefit based on over 70 studies and over 33 randomized trials where there is about a 56% benefit....When someone pitches in a 500 patient trial.. not blinded, no placebo.. and the doctors decide the endpoint, which is how much oxygen patients get, that's a biased endpoint. When the headlines say that the trial overturned the entire science on ivermectin, that's clearly an overstatement."
Rumble Clip | Source | Dr. Pierre Kory's Article
@KanekoaTheGreat
"There's a signal of benefit based on over 70 studies and over 33 randomized trials where there is about a 56% benefit....When someone pitches in a 500 patient trial.. not blinded, no placebo.. and the doctors decide the endpoint, which is how much oxygen patients get, that's a biased endpoint. When the headlines say that the trial overturned the entire science on ivermectin, that's clearly an overstatement."
Rumble Clip | Source | Dr. Pierre Kory's Article
@KanekoaTheGreat
"The hospital was interfering with my ability to practice medicine. I stood by idly while all 7 of my patients died." Listen to Dr. Marik's podcast with Tommy Carrigan as he describes the enormous power hospitals have over physicians. https://t.co/UVAlxSuNoz https://t.co/tSgHk2NNF4
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 24, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 24, 2022
Spotify
TPC #684: Dr. Paul Marik (Regulatory Capture & Nuremberg 2.0)
Listen to this episode from Tommy's PodCast on Spotify. TPC #684: Dr. Paul Marik (Regulatory Capture & Nuremberg 2.0) TPC #684 is with Dr. Paul Marik. Dr Marik received his medical degree from the University of the Witwatersrand, Johannesburg, South Africa.…
By now, we know that early treatment works for COVID-19. There are safe, inexpensive and effective options available. The key is to be ready to treat as soon as symptoms appear. Are you prepared? https://t.co/LKwURDfEL2
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 24, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 24, 2022
Twitter
FLCCC—Front Line COVID-19 Critical Care Alliance
By now, we know that early treatment works for COVID-19. There are safe, inexpensive and effective options available. The key is to be ready to treat as soon as symptoms appear. Are you prepared?
👍1
"In times of upheaval, calamity or disaster, Mr. Rogers always advised to, 'Look for the helpers. There are always helpers.'” Don't miss this heartfelt tribute to the healthcare heros who've risked their lives to save lives in the midst of this pandemic. https://t.co/xY43SGl0iT
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 24, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 24, 2022
Bywords
After 2 Years of Censorship— & Trying to Help Save Lives — I Just Needed to Hear Mr. Rogers’ Voice
Dedicated to the healthcare heroes around the world—many who risked their livelihoods to save lives
Did you miss last night's webinar? Watch as Andy Schlafly, Esq, General Counsel of the Association of American Physicians and Surgeons joined Dr. Marik and Dr. Varon to discuss sham peer reviews, why they are becoming more common and the modern hospital. https://t.co/PkJcizBjEJ https://t.co/i8ZHIKMhON
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 25, 2022
— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) Feb 25, 2022
Odysee
Sham Peer Review and the Impact on Doctors: FLCCC Weekly Webinar 23 February, 2022
Dr. Marik discusses sham peer reviews with Dr. Joe Varon & Andrew Schlafly, general counsel for the Association of American Physicians & Surgeons. What are sham peer reviews and why are they becoming ...
Forwarded from BiRD Group Channel (Rob Trup)
bree block350.png
14.8 KB
Proof #5 that Ivermectin Works
Title: Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City.” SocArXiv, May 3, 2021. Doi: 10.31235/osf.io/r93g4
From the authors: We estimated logistic-regression models with matched observations adjusting by age, sex, COVID severity, and comorbidities. We found a significant reduction in hospitalizations among patients who received the ivermectin-based medical kit; the range of the effect is 52% – 76% depending on model specification.”
Read the report here: https://earlycovidcare.org/wp-content/uploads/2021/07/Ivermectin-and-the-odds-of-hospitalization-due-to-COVID.pdf
Title: Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City.” SocArXiv, May 3, 2021. Doi: 10.31235/osf.io/r93g4
From the authors: We estimated logistic-regression models with matched observations adjusting by age, sex, COVID severity, and comorbidities. We found a significant reduction in hospitalizations among patients who received the ivermectin-based medical kit; the range of the effect is 52% – 76% depending on model specification.”
Read the report here: https://earlycovidcare.org/wp-content/uploads/2021/07/Ivermectin-and-the-odds-of-hospitalization-due-to-COVID.pdf
Forwarded from BiRD Group Channel (Linda FM)
英語）2022年1月22日「世界イベルメクチンデー制定記念市民公開講座」抄録.pdf
658.2 KB
Here is the Summary of the Symposium to commemorate the World Ivermectin Day on 22nd January 2022 in Okayama Japan, where the Distinguished Emeritus Professor, Dr Satoshi Omura, made an impassioned speech titled “Infectious diseases and Sincerity and Compassion”.
In the words of Nojima Toru, representative of the Okayama Wisemen Club: “We hope not only Japanese but also the people in the world acknowledge the effectiveness of Ivermectin.”
-The Bird Team
In the words of Nojima Toru, representative of the Okayama Wisemen Club: “We hope not only Japanese but also the people in the world acknowledge the effectiveness of Ivermectin.”
-The Bird Team